CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Su, Y.
Right arrow Articles by Zheng, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Su, Y.
Right arrow Articles by Zheng, W.
Related Collections
Right arrow Oncogenesis
Right arrow Oncogenesis: Biomarkers
Right arrow Oncogenesis: Intraepithelial Neoplasia/Premalignancy
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 1719-1726, September 2006
© 2006 American Association for Cancer Research

Immunohistochemical Expressions of Ki-67, Cyclin D1, ß-Catenin, Cyclooxygenase-2, and Epidermal Growth Factor Receptor in Human Colorectal Adenoma: A Validation Study of Tissue Microarrays

Yinghao Su1, Martha J. Shrubsole1, Reid M. Ness2, Qiuyin Cai1, Nobuhiko Kataoka1, Kay Washington3 and Wei Zheng1

1 Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt-Ingram Cancer Center and Vanderbilt Epidemiology Center, 2 Division of Gastroenterology, Hepatology, and Nutrition, Departments of Medicine and 3 Pathology, Vanderbilt University Medical Center, Nashville, Tennessee

Requests for reprints: Wei Zheng, Vanderbilt University Medical Center, S-1121A Medical Center North, Nashville, TN 37232-2587. Phone: 615-936-0682; Fax: 615-322-1754. E-mail: wei.zheng{at}vanderbilt.edu

Background: Tissue microarray (TMA) holds promise as a high-throughput method for the analysis of biomarkers in tissue specimens. The validity and reliability of this method, however, may vary for different biomarkers in different tissue specimens.

Objectives: In this study, we evaluated the validity and reliability of using TMA to assess biomarkers in colorectal adenomas.

Methods: Sixty-three consecutive patients with colorectal adenomas were recruited in this study. Two TMA blocks were constructed using four punches from each adenoma (one periphery, one deep, and two middle zones). The immunostaining of five markers (Ki-67, cyclin D1, ß-catenin, cyclooxygenase-2, and epidermal growth factor receptor) was analyzed, and the concordance between data obtained from TMAs and standard whole-tissue sections was evaluated by Spearman's correlation and kappa analysis.

Results: Colorectal adenoma exhibited zonal, heterogeneous expression patterns for all five markers. The concordance rates for the semiquantitative evaluation of markers between data from TMAs and whole sections ranged from 87% to 93% with corresponding kappa statistics of 77% to 90%. In addition, both quantitative and semiquantitative methods were used to score TMA sections, and good correlations between these two methods were shown for all five markers with intraclass correlation coefficients ranging from 0.5 to 0.8.

Conclusion: Our study indicates that TMA can be used to reliably assess the expression levels of Ki-67, cyclin D1, ß-catenin, cyclooxygenase-2, and epidermal growth factor receptor in colorectal adenoma tissues. (Cancer Epidemiol Biomarkers Prev 2006;15(9):1719–26)




This article has been cited by other articles:


Home page
Ann OncolHome page
M. J. E. M. Gosens, R. C. Dresen, H. J. T. Rutten, G. A. P. Nieuwenhuijzen, J. A. W. M. van der Laak, H. Martijn, I. Tan-Go, I. D. Nagtegaal, A. J. C. van den Brule, and J. H. J. M. van Krieken
Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours
Ann. Onc., July 29, 2008; (2008) mdn428v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.